Cargando…

Association Analysis Between Catechol-O-Methyltransferase Expression and Cognitive Function in Patients with Schizophrenia, Bipolar Disorder, or Major Depression

INTRODUCTION: Schizophrenia, bipolar disorder (BD), and major depressive disorder are three common mental disorders. Although their diagnosis and treatment differ, they partially overlap. METHODS: To explore the similarities and characteristics of these three psychiatric diseases, an intelligence qu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Peiyan, Liu, Manli, Wang, Dequan, Tian, Yang, Zhao, Liansheng, Wei, Jinxue, Yu, Xueli, Qi, Xueyu, Li, Xiaojing, Yu, Hua, Ni, Rongjun, Ma, Xiaohong, Deng, Wei, Guo, Wanjun, Wang, Qiang, Li, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910219/ https://www.ncbi.nlm.nih.gov/pubmed/33654399 http://dx.doi.org/10.2147/NDT.S286102

Ejemplares similares

Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder: associations with clinical symptoms and cognitive function
por: Yu, Hua, et al.
Publicado: (2023)

Disrupted association between structural and functional coupling of the supplementary motor area and neurocognition in major depressive disorder
por: Wei, Jinxue, et al.
Publicado: (2023)

YBX1‐Mediated DNA Methylation‐Dependent SHANK3 Expression in PBMCs and Developing Cortical Interneurons in Schizophrenia
por: Ni, Peiyan, et al.
Publicado: (2023)

YBX1‐Mediated DNA Methylation‐Dependent SHANK3 Expression in PBMCs and Developing Cortical Interneurons in Schizophrenia (Adv. Sci. 20/2023)
por: Ni, Peiyan, et al.
Publicado: (2023)

Identifying transdiagnostic biological subtypes across schizophrenia, bipolar disorder, and major depressive disorder based on lipidomics profiles
por: Tao, Shiwan, et al.
Publicado: (2022)

Association of elevated levels of peripheral complement components with cortical thinning and impaired logical memory in drug-naïve patients with first-episode schizophrenia
por: Yu, Hua, et al.
Publicado: (2023)

The level of IL-6 was associated with sleep disturbances in patients with major depressive disorder
por: Wang, Min, et al.
Publicado: (2019)

Plasma complement component 4 increases in patients with major depressive disorder
por: Wei, Jinxue, et al.
Publicado: (2017)

Valproate Reverses Mania-Like Behavior of Clock(delta19) Mouse and Alters Monoamine Neurotransmitters Metabolism in the Hippocampus
por: Liu, Shasha, et al.
Publicado: (2021)

Plasma metabolites were associated with spatial working memory in major depressive disorder
por: Du, Yue, et al.
Publicado: (2021)

A Whole Transcriptome Analysis in Peripheral Blood Suggests That Energy Metabolism and Inflammation Are Involved in Major Depressive Disorder
por: Wang, Yu, et al.
Publicado: (2022)

Differential Cortical Gray Matter Deficits in Adolescent- and Adult-Onset First-Episode Treatment-Naïve Patients with Schizophrenia
por: Zhang, Chengcheng, et al.
Publicado: (2017)

The Influence of the Val158Met Catechol-O-Methyltransferase Polymorphism on the Personality Traits of Bipolar Patients
por: Dávila, Wendy, et al.
Publicado: (2013)

Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia
por: Han, Jiyang, et al.
Publicado: (2017)

Inhibition of catechol-O-methyltransferase by natural pentacyclic triterpenes: structure–activity relationships and kinetic mechanism
por: Wang, Fang-Yuan, et al.
Publicado: (2021)

Analytical methodologies for sensing catechol-O-methyltransferase activity and their applications
por: Wang, Fang-Yuan, et al.
Publicado: (2021)

Catechol-O-methyltransferase (COMT) polymorphisms modulate working memory in individuals with schizophrenia and healthy controls
por: Matsuzaka, Camila T., et al.
Publicado: (2017)

Catechol‐O‐Methyltransferase and Cardiovascular Disease: MESA
por: Hall, Kathryn T., et al.
Publicado: (2019)

Partitioning of Catechol Derivatives in Lipid Membranes: Implications for Substrate Specificity to Catechol-O-methyltransferase
por: Parkkila, Petteri, et al.
Publicado: (2020)

Catechol-O-methyltransferase: potential relationship to idiopathic hypertension
por: Mantione, Kirk J., et al.
Publicado: (2010)

Genetics of headache and catechol–O–methyltransferase gene polymorphism
por: Bayazit, Yildirim A.
Publicado: (2006)

Mapping the conformational space accessible to catechol-O-methyltransferase
por: Ehler, Andreas, et al.
Publicado: (2014)

Hypnotizability and Catechol-O-Methyltransferase (COMT) polymorphysms in Italians
por: Presciuttini, Silvano, et al.
Publicado: (2014)

Inhibitory Effect of Bovine Lactoferrin on Catechol-O-Methyltransferase
por: Ikeda, Masayuki, et al.
Publicado: (2017)

Catechol-O-methyltransferase, a new target for pancreatic cancer therapy
por: Wu, Wenming, et al.
Publicado: (2015)

Synthesis and Evaluation of Bicyclic Hydroxypyridones as Inhibitors of Catechol O-Methyltransferase
por: Ernst, Glen, et al.
Publicado: (2019)

Haplotypic and Genotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Polymorphisms and Treatment Resistance in Schizophrenia
por: Sagud, Marina, et al.
Publicado: (2018)

Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia
por: Nikolac Perkovic, Matea, et al.
Publicado: (2020)

Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder
por: Du, Yue, et al.
Publicado: (2021)

Characterization of NF-kB-mediated inhibition of catechol-O-methyltransferase
por: Tchivileva, Inna E, et al.
Publicado: (2009)

Structural Mechanism of S-Adenosyl Methionine Binding to Catechol O-Methyltransferase
por: Tsao, Douglas, et al.
Publicado: (2011)

Suppressor effect of catechol-O-methyltransferase gene in prostate cancer
por: Hashimoto, Yutaka, et al.
Publicado: (2021)

Catechol-O-methyltransferase Inhibitors from Calendula officinalis Leaf
por: Kadowaki, Wataru, et al.
Publicado: (2023)

A Novel Catechol-O-Methyltransferase Variant Associated with Human Disc Degeneration
por: Gruber, Helen E., et al.
Publicado: (2014)

Discovery and characterization of naturally occurring potent inhibitors of catechol-O-methyltransferase from herbal medicines
por: Zhao, Dong-Fang, et al.
Publicado: (2021)

Polymorphism of the catechol-O-methyltransferase gene in Han Chinese patients with psoriasis vulgaris
por: Gao, Lin, et al.
Publicado: (2009)

Cannabis, Schizophrenia Risk and Genetics: A Case Report of a Patient With Homozygous Valine Catechol-O-Methyltransferase Polymorphism
por: Grechuk, Katelyn, et al.
Publicado: (2021)

Toxoplasma gondii Seropositivity Interacts with Catechol-O-methyltransferase Val105/158Met Variation Increasing the Risk of Schizophrenia
por: Rovira, Paula, et al.
Publicado: (2022)

Convergent Mechanistic Features between the Structurally Diverse N- and O-Methyltransferases: Glycine N-Methyltransferase and Catechol O-Methyltransferase
por: Zhang, Jianyu, et al.
Publicado: (2016)

S179. PROGNOSTIC UTILITY OF MULTIVARIATE MORPHOMETRY IN SCHIZOPHRENIA
por: Li, Mingli, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dpun1fu4k5j6a9k65eippjvtqc